Rigel Pharmaceuticals | RIGL - سرمایه گذاری در بازار





سرمایه گذاری در بازار تغییر دادن تاریخ
Agenus USD 107M 16M 2025-12
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Celldex Therapeutics USD 1.81B 87M 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Veracyte USD 3.33B 627M 2025-12